Objective:

To address unmet needs in heart failure therapy by integrating insights from molecular biology, translational research, and clinical practice, focusing on the persistent gaps in therapeutic outcomes.

Approach:

• Mechanistic Investigations: Studies explored disease mechanisms, including early treatment with nootkatone, which prevents pressure overload-induced ventricular remodeling, and the effects of Poge heart-saving decoction on apoptosis and fibrosis via PI3 K/AKT regulation.
• Therapeutic Evaluations: Reassessments of established interventions, such as cardiac resynchronization therapy and beta-blockers, alongside evaluations of novel agents like vericiguat and finerenone, highlighted advancements in heart failure treatment.
• Clinical Perspectives: Investigations focused on drug resistance, adverse effects, and treatment access disparities, emphasizing the need for individualized therapy tailored to patient characteristics.

Key Findings:

• Nootkatone prevents pressure overload-induced ventricular remodeling.
• Poge heart-saving decoction mitigates apoptosis and fibrosis via PI3 K/AKT regulation.
• HIF-mediated hierarchical adaptation is a novel paradigm in heart failure pathogenesis.
• Emerging agents like vericiguat and finerenone show promise in improving outcomes.
• Multi-omics approaches and biomarkers such as CLU, FOS, and CXCL8 are identified for disease progression.

Interpretation:

This collection provides a comprehensive synthesis of mechanistic, therapeutic, and clinical dimensions of heart failure therapy, reflecting significant advancements and ongoing challenges in the field.

Limitations:

• High rates of hospitalization and mortality persist despite advancements in heart failure therapy.
• Challenges in care delivery and treatment access remain significant, impacting patient outcomes.

Conclusion:

The contributions illustrate both progress and ongoing challenges in heart failure care, emphasizing the integration of mechanistic discoveries with therapeutic innovation to improve patient outcomes.